Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1475, doi. 10.1038/sj.onc.1206196
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2003 AND VI 22 AND IP 10
Results: 15
1
2
Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1491, doi. 10.1038/sj.onc.1206169
- By:
- Publication type:
- Article
3
Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1568, doi. 10.1038/sj.onc.1206219
- By:
- Publication type:
- Article
4
PDGF-D is a potent transforming and angiogenic growth factor.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1501, doi. 10.1038/sj.onc.1206223
- By:
- Publication type:
- Article
5
Alterations of anaphase-promoting complex genes in human colon cancer cells.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1486, doi. 10.1038/sj.onc.1206224
- By:
- Publication type:
- Article
6
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1517, doi. 10.1038/sj.onc.1206226
- By:
- Publication type:
- Article
7
Wnt signaling in B-cell neoplasia.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1536, doi. 10.1038/sj.onc.1206239
- By:
- Publication type:
- Article
8
Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1580, doi. 10.1038/sj.onc.1206243
- By:
- Publication type:
- Article
9
Quantitation of HERV-K env gene expression and splicing in human breast cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1528, doi. 10.1038/sj.onc.1206241
- By:
- Publication type:
- Article
10
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1431, doi. 10.1038/sj.onc.1206258
- By:
- Publication type:
- Article
11
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S?phase.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1445, doi. 10.1038/sj.onc.1206264
- By:
- Publication type:
- Article
12
The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1461, doi. 10.1038/sj.onc.1206266
- By:
- Publication type:
- Article
13
Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1546, doi. 10.1038/sj.onc.1206284
- By:
- Publication type:
- Article
14
Presenilin-dependent ?-secretase activity mediates the intramembranous cleavage of CD44.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1511, doi. 10.1038/sj.onc.1206298
- By:
- Publication type:
- Article
15
Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
- Published in:
- Oncogene, 2003, v. 22, n. 10, p. 1557, doi. 10.1038/sj.onc.1206299
- By:
- Publication type:
- Article